Tropogenix, Inc. — Form D/A
Tropogenix, Inc. of SAN ANTONIO, TX, a company, filed a Form D amendment with the SEC on 2025-09-30. The offering totals $2.5M, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-30
- Form: D/A
- Accession: 0002086858-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $250K
- Remaining: $2.3M
- Investors: 1
- Date of first sale: 2025-09-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-558278
Issuer
- Name: Tropogenix, Inc.
- CIK: 0002086858
- Entity type: Corporation
- Jurisdiction: TEXAS
- Incorporated: 2025
- Address: 4725 COLLEGE PARK, SAN ANTONIO, TX, 78249
- Phone: 210-667-7920
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Paul Castella | Director | San Antonio, TX |
| Bryan Daniels | Director | Issaquah, WA |
| Kevin Meehan | Director | Hong Kong, K3 |
| Kristen Parker | Director | San Antonio, TX |
| Paul Castella | Executive Officer | San Antonio, TX |
Other filings by this issuer (1)
More